Sign in

You're signed outSign in or to get full access.

Cassiopeia Olson

Director at Atlas Lithium
Board

About Cassiopeia Olson

Independent director at Atlas Lithium (ATLX) since 2021; attorney specializing in international contracts, securities law, and venture negotiations. Education: B.A. in Economics & Finance (Loyola University Chicago) and J.D. (The John Marshall School of Law). Currently with Mitchell Silberberg & Knupp (since May 2022); previously with Ellenoff Grossman & Schole, Crone Law Group, and Kaplowitz Firm P.C. The Board has determined she is independent under Nasdaq rules .

Past Roles

OrganizationRoleTenureCommittees/Impact
Kaplowitz Firm P.C.Attorney2013–2017International contracts and venture transactions
Crone Law GroupAttorney2017–Jan 2020Securities law and transactions
Ellenoff Grossman & Schole LPAttorneyFeb 2020–May 2022Securities law; venture negotiations

External Roles

OrganizationRoleTenureNotes
Mitchell Silberberg & KnuppAttorneyMay 2022–presentCorporate/securities; international transactions
Other public company boardsNone disclosed

Board Governance

  • Independence: Olson is one of three independent directors (with Noriega and Petersen) as determined under Nasdaq rules .
  • Committees: Audit (member), Compensation (member), Nominations (member); Audit chaired by Stephen R. Petersen, CFA .
  • Attendance: In FY2024, Board met/acted 25 times; Audit 8, Compensation 1, Nominations 1. All directors attended at least 75% of Board and committee meetings; all attended the 2024 annual meeting .
  • Controlled company: CEO/Chair Marc Fogassa controls ~65.6% of voting power via one Series A preferred share conferring 51% voting rights plus common ownership; company is a “controlled company,” currently not relying on Nasdaq controlled-company exemptions .
  • Policies: Insider Trading Policy; Hedging prohibited for directors/officers/employees; Clawback Policy compliant with SEC/Nasdaq Rule 5608 for incentive comp restatements .

Fixed Compensation

ComponentFY 2024 AmountNotes
Annual cash retainer$0 No director cash fees; program is equity-only
Meeting fees$0 “No other or additional compensation”; no meeting fees disclosed
Committee membership/chair feesNot disclosed Not separately specified

Performance Compensation

Award TypeGrant DateShares/OptionsExercise/StrikeVestingFair Value
Non-qualified stock options (annual program)2024 cycle10,000 options $0.0075 per share Monthly vest over 1 year $312,705 (grant-date fair value)
Non-qualified stock options (annual program)Jan 202510,000 options $0.0075 per share Monthly vest over 1 year; cancellable if shareholders don’t approve Proposal 3 Not disclosed; closing price was $5.28 on Apr 1, 2025 for context

Performance Metrics: None—director options are time-based, with no performance conditions (monthly vesting; deep in-the-money exercise price relative to market) .

Other Directorships & Interlocks

CategoryDetail
Current public company boardsNone disclosed
Prior public company boardsNone disclosed
Interlocks with competitors/suppliers/customersNone disclosed

Expertise & Qualifications

  • Securities law, international contracts, venture negotiations; experience with large multinational transactions .
  • Education: B.A. Economics/Finance (Loyola University Chicago); J.D. (The John Marshall School of Law) .
  • Board service since 2021; multi-committee engagement (Audit, Compensation, Nominations) .

Equity Ownership

As of Record DateDirect CommonOptions (vested and within 60 days)Total Beneficial% of OutstandingCombined Voting Power
April 1, 20251,071 shares 24,833 shares 25,905 shares 0.1% 0.1%

Additional context:

  • Shares outstanding: 17,498,904 common shares; one Series A preferred share confers 51% of total voting power to Mr. Fogassa .
  • Hedging prohibited by policy (alignment-positive) .
  • Ownership guidelines for directors: Not disclosed .

Insider Trades and Filing Compliance

Item2024
Late Form 4 filings1 (Olson)
Late Form 5 filings1 (Olson; grant that should have been reported in 2023)

Note: Company disclosed late filings across multiple insiders; Olson’s late Form 4 and Form 5 are minor compliance lapses but merit monitoring .

Governance Assessment

  • Strengths:

    • Independent status; active service on all three key committees (Audit, Compensation, Nominations) .
    • Board/committee meeting participation overall strong (≥75% for all directors) .
    • Robust governance policies: hedging ban and SEC/Nasdaq-compliant clawback .
    • No related-party transactions disclosed involving Olson .
  • Concerns / RED FLAGS:

    • Controlled company dynamics: CEO/Chair holds ~65.6% voting power including Series A preferred conferring 51% voting rights, increasing reliance on board independence and committee rigor .
    • Director equity structure: options granted deeply in-the-money (exercise price $0.0075 vs $5.28 market on Apr 1, 2025), which creates guaranteed value and reduces performance sensitivity relative to typical at-the-money grants; monthly vesting without performance metrics .
    • Section 16(a) compliance: Olson filed one late Form 4 and one late Form 5 in 2024; monitor filing timeliness .
  • Shareholder feedback signals:

    • 2024 say-on-pay for NEOs received ~97% approval; frequency vote favored biennial (~94%)—indicates general investor support for compensation framework (NEOs), though Proposal 3 in 2025 seeks explicit approval of non-employee director compensation for option program continuation .

Implications for board effectiveness and investor confidence:

  • Olson’s legal and securities background is well-suited to oversight within Audit, Compensation, and Nominations, supporting process integrity .
  • However, the director equity program’s deep ITM option design and lack of performance conditions weaken pay-for-performance alignment and may attract governance scrutiny; investors may prefer RSUs or at-the-money options tied to measurable targets .
  • Controlled-company status heightens the need for independent directors to assert robust oversight; Olson’s multi-committee participation is positive, but adherence to filing timeliness must be consistent to maintain governance credibility .

Appendix: Key Committee Assignments

CommitteeMembersChairMandate
AuditNoriega; Olson; PetersenPetersen Financial reporting integrity; auditor oversight; risk and cybersecurity oversight
CompensationNoriega; OlsonNot disclosed Exec/director comp policies; incentive plans; consultant oversight (no consultant currently retained)
NominationsOlson; PetersenNot disclosed Board composition; director nominations; governance guidelines; annual board performance review